The document discusses the historical use of psychotropic drugs by militaries to enhance performance and numb trauma, as well as the contemporary use of these drugs by the US military to treat mental health conditions. It notes that 20% of active duty troops surveyed in 2010 were taking psychotropic medications. The document outlines some of the bioethical concerns regarding conflicts between military needs and patient needs. It summarizes clinical practice guidelines from 2013 regarding deployment while taking these medications. A case study illustrates the risks of abruptly changing medications. The conclusion calls for continued research on safer drugs, improved formularies and supply chains, and regular updates to the clinical guidelines.